HC Wainwright & Co. Maintains Buy on HIVE Blockchain Techs, Raises Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mike Colonnese maintains a 'Buy' rating on HIVE Blockchain Techs and raises the price target from $5 to $7.
July 05, 2023 | 4:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The 'Buy' rating maintained by HC Wainwright & Co. and the raised price target could potentially boost HIVE Blockchain Techs' stock in the short term.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, the 'Buy' rating maintained by HC Wainwright & Co. and the raised price target from $5 to $7 indicates a positive outlook for HIVE Blockchain Techs, which could potentially boost its stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100